![Le directeur financier Harry Kirsch du drugmaker suisse Novartis s'adresse à la conférence de presse annuelle de la société à Bâle, en Suisse, le 30 janvier 2019. REUTERS/Arnd Wiegmann Photo Stock - Le directeur financier Harry Kirsch du drugmaker suisse Novartis s'adresse à la conférence de presse annuelle de la société à Bâle, en Suisse, le 30 janvier 2019. REUTERS/Arnd Wiegmann Photo Stock -](https://c8.alamy.com/compfr/2cjb0k4/le-directeur-financier-harry-kirsch-du-drugmaker-suisse-novartis-s-adresse-a-la-conference-de-presse-annuelle-de-la-societe-a-bale-en-suisse-le-30-janvier-2019-reuters-arnd-wiegmann-2cjb0k4.jpg)
Le directeur financier Harry Kirsch du drugmaker suisse Novartis s'adresse à la conférence de presse annuelle de la société à Bâle, en Suisse, le 30 janvier 2019. REUTERS/Arnd Wiegmann Photo Stock -
![CFO Harry Kirsch of Swiss pharmaceutical company Novartis addresses the company's annual news conference in Basel, Switzerland January 27, 2016. Novartis said it will replace the management of its eye care division CFO Harry Kirsch of Swiss pharmaceutical company Novartis addresses the company's annual news conference in Basel, Switzerland January 27, 2016. Novartis said it will replace the management of its eye care division](https://c8.alamy.com/comp/2CM5P58/cfo-harry-kirsch-of-swiss-pharmaceutical-company-novartis-addresses-the-companys-annual-news-conference-in-basel-switzerland-january-27-2016-novartis-said-it-will-replace-the-management-of-its-eye-care-division-alcon-after-the-swiss-drugmaker-missed-fourth-quarter-earnings-expectations-and-said-overall-2016-sales-and-profit-will-likely-stagnate-amid-3-billion-in-patent-expirations-reutersarnd-wiegmann-2CM5P58.jpg)
CFO Harry Kirsch of Swiss pharmaceutical company Novartis addresses the company's annual news conference in Basel, Switzerland January 27, 2016. Novartis said it will replace the management of its eye care division
Nef Roldan - Project Manager: Integration Manager – Supply Chain - Novartis Pharmaceuticals | LinkedIn
![CFO Harry Kirsch of Swiss drugmaker Novartis addresses the company's annual news conference in Basel, Switzerland January 30, 2019. REUTERS/Arnd Wiegmann Stock Photo - Alamy CFO Harry Kirsch of Swiss drugmaker Novartis addresses the company's annual news conference in Basel, Switzerland January 30, 2019. REUTERS/Arnd Wiegmann Stock Photo - Alamy](https://c8.alamy.com/comp/2CHCBJ3/cfo-harry-kirsch-of-swiss-drugmaker-novartis-addresses-the-companys-annual-news-conference-in-basel-switzerland-january-30-2019-reutersarnd-wiegmann-2CHCBJ3.jpg)
CFO Harry Kirsch of Swiss drugmaker Novartis addresses the company's annual news conference in Basel, Switzerland January 30, 2019. REUTERS/Arnd Wiegmann Stock Photo - Alamy
![Harry Kirsch Chief Financial Officer Swiss Editorial Stock Photo - Stock Image | Shutterstock | Shutterstock Editorial Harry Kirsch Chief Financial Officer Swiss Editorial Stock Photo - Stock Image | Shutterstock | Shutterstock Editorial](https://editorial01.shutterstock.com/wm-preview-1500/8130694h/70b1f8c2/Shutterstock_8130694h.jpg)
Harry Kirsch Chief Financial Officer Swiss Editorial Stock Photo - Stock Image | Shutterstock | Shutterstock Editorial
![Harry Kirsch L Chief Financial Office Editorial Stock Photo - Stock Image | Shutterstock | Shutterstock Editorial Harry Kirsch L Chief Financial Office Editorial Stock Photo - Stock Image | Shutterstock | Shutterstock Editorial](https://editorial01.shutterstock.com/wm-preview-1500/10076854h/521dbc29/Shutterstock_10076854h.jpg)
Harry Kirsch L Chief Financial Office Editorial Stock Photo - Stock Image | Shutterstock | Shutterstock Editorial
Harry Kirsch, chief financial officer of Novartis AG, pauses during a... Fotografía de noticias - Getty Images
![CEO Vas Narasimhan of Swiss drugmaker Novartis sits beside as CFO Harry Kirsch addresses the company's annual news conference in Basel, Switzerland January 30, 2019. REUTERS/Arnd Wiegmann Stock Photo - Alamy CEO Vas Narasimhan of Swiss drugmaker Novartis sits beside as CFO Harry Kirsch addresses the company's annual news conference in Basel, Switzerland January 30, 2019. REUTERS/Arnd Wiegmann Stock Photo - Alamy](https://c8.alamy.com/comp/2CJB0K0/ceo-vas-narasimhan-of-swiss-drugmaker-novartis-sits-beside-as-cfo-harry-kirsch-addresses-the-companys-annual-news-conference-in-basel-switzerland-january-30-2019-reutersarnd-wiegmann-2CJB0K0.jpg)
CEO Vas Narasimhan of Swiss drugmaker Novartis sits beside as CFO Harry Kirsch addresses the company's annual news conference in Basel, Switzerland January 30, 2019. REUTERS/Arnd Wiegmann Stock Photo - Alamy
![Harry Kirsch L Chief Financial Office Editorial Stock Photo - Stock Image | Shutterstock | Shutterstock Editorial Harry Kirsch L Chief Financial Office Editorial Stock Photo - Stock Image | Shutterstock | Shutterstock Editorial](https://editorial01.shutterstock.com/wm-preview-1500/10076854j/8901f425/Shutterstock_10076854j.jpg)